Amarin says Sky won't go down in the fight for skinny labels

By Andrew Karpan (October 2, 2024, 8:14 p.m. EDT) — Amarin Pharma Inc., the maker of the cardiovascular drug Vascepa, has defended a Federal Court decision to reopen its skinny-label patent case against a rival British drugmaker Court of Appeal that “the sky will not fall on the generic drug industry”.

Law360 is there, so you are too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments, so you can act quickly and confidently. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features like

• Daily newsletters
• Expert analysis
• Mobile app
• Advanced search
• Information about the judge
• Real-time alerts
• Over 450,000 searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.